The role of microglia in early neurodevelopment and the effects of maternal immune activation

L J M Mastenbroek1, S M Kooistra2, B J L Eggen2

  • 1Department of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

PubMed

Insights

Maternal immune activation during pregnancy may increase neurodevelopmental disorder risk in offspring. Microglia (brain immune cells) play a key role, with early life priming potentially linked to these disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Developmental Biology

Background:

  • Maternal immune activation during pregnancy is linked to offspring neurodevelopmental disorders like schizophrenia and autism spectrum disorder.
  • Microglia, the brain's resident immune cells, are crucial for early neurodevelopment and may mediate this risk.
  • The timing of immune activation can disrupt microglia function, causing lasting effects.

Purpose of the Study:

  • To review the role of microglia in prenatal and early postnatal brain development.
  • To examine the impact of maternal immune activation on microglia and neurodevelopment.
  • To explore the connection between early microglial priming and neurodevelopmental disorders.

Main Methods:

  • Review of existing literature on maternal immune activation and neurodevelopment.
  • Analysis of microglia's role in embryonic and early postnatal brain development.
  • Discussion of single-cell RNA-sequencing data on prenatal microglia.

Main Results:

  • Microglia are involved in critical neurodevelopmental processes beyond immune response.
  • Maternal immune activation can alter microglia function during sensitive developmental windows.
  • Early microglial priming, potentially via epigenetic changes, is hypothesized to contribute to neurodevelopmental disorders.

Conclusions:

  • Microglia are central players in how maternal immune activation affects offspring neurodevelopment.
  • Understanding microglia's early life programming is key to addressing neurodevelopmental disorder risks.
  • Further research into microglial epigenetic reprogramming may reveal therapeutic targets.